Cyclosporine Neoral in Renal Transplant Recipients: Impact on Hepatic Dysfunction

By Bakr M.A.   Refaie A.   Mekresh M.   Ihab M.H.   Sobh M.   Ghoneim M.A.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2939-2940

Elsevier

Access to resources Recommend Favorite

Arterial hypertension in renal transplant recipients treated with tacrolimus or cyclosporine-neoral

By Nichelle L.   Canet S.   Garrigue V.   Chong G.   Mourad G.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2824-2825

Elsevier

Access to resources Recommend Favorite

Use of cyclosporine mepc (neoral) in heart transplant recipients

By Fukushima N.   Ohtake S.   Sawa Y.   Nishimura M.   Kobayashi Y.   Shirakura R.   Nakata S.   Matsuda H.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3337-3338

Elsevier

Access to resources Recommend Favorite

Estimation of mean relative bioavailability of cyclosporine sandimmune and neoral using NONMEM in renal transplant recipients

By Lee K.L.   Lee K.T.   Chung H.M.   Lin Y.P.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3526-3529

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic Cyclosporine A Profiles Under Long-Term Neoral Treatment in Renal Transplant Recipients: Does Fat Intake Still Matter?

By Klauser R.M.   Irschik H.   Kletzmayr J.   Sturm I.   Brunner W.   Woloszczuk W.   Kovarik J.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 3137-3140

Elsevier

Access to resources Recommend Favorite